» Articles » PMID: 18772204

Myocardial Blood Flow and Adenosine A2A Receptor Density in Endurance Athletes and Untrained Men

Abstract

Previous human studies have shown divergent results concerning the effects of exercise training on myocardial blood flow (MBF) at rest or during adenosine-induced hyperaemia in humans. We studied whether these responses are related to alterations in adenosine A2A receptor (A2AR) density in the left-ventricular (LV) myocardium, size and work output of the athlete's heart, or to fitness level. MBF at baseline and during intravenous adenosine infusion, and A2AR density at baseline were measured using positron emission tomography, and by a novel A(2A)R tracer in 10 healthy male endurance athletes (ET) and 10 healthy untrained (UT) men. Structural LV parameters were measured with echocardiography. LV mass index was 71% higher in ET than UT (193 +/- 18 g m(-2) versus 114 +/- 13 g m(-2), respectively). MBF per gram of tissue was significantly lower in the ET than UT at baseline, but this was only partly explained by reduced LV work load since MBF corrected for LV work was higher in ET than UT, as well as total MBF. The MBF during adenosine-induced hyperaemia was reduced in ET compared to UT, and the fitter the athlete was, the lower was adenosine-induced MBF. A2AR density was not different between the groups and was not coupled to resting or adenosine-mediated MBF. The novel findings of the present study show that the adaptations in the heart of highly trained endurance athletes lead to relative myocardial 'overperfusion' at rest. On the other hand hyperaemic perfusion is reduced, but is not explained by A2AR density.

Citing Articles

Myocardial blood flow in newly diagnosed breast cancer patients at rest and during exercise.

Koivula T, Uurasmaa T, Han C, Maaniitty T, Latifi S, Lempiainen S iScience. 2024; 27(11):111081.

PMID: 39507255 PMC: 11539585. DOI: 10.1016/j.isci.2024.111081.


Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice.

Gundel D, Lai T, Dukic-Stefanovic S, Teodoro R, Deuther-Conrad W, Toussaint M Int J Mol Sci. 2022; 23(3).

PMID: 35162950 PMC: 8835051. DOI: 10.3390/ijms23031025.


Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation....

Koller A, Laughlin M, Cenko E, De Wit C, Toth K, Bugiardini R Cardiovasc Res. 2021; 118(2):357-371.

PMID: 34358290 PMC: 8803083. DOI: 10.1093/cvr/cvab246.


Allosteric Interactions between Adenosine A and Dopamine D Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Prasad K, de Vries E, Elsinga P, Dierckx R, van Waarde A Int J Mol Sci. 2021; 22(4).

PMID: 33572077 PMC: 7915359. DOI: 10.3390/ijms22041719.


Cardiac hypoxic resistance and decreasing lactate during maximum apnea in elite breath hold divers.

Kjeld T, Moller J, Fogh K, Hansen E, Arendrup H, Isbrand A Sci Rep. 2021; 11(1):2545.

PMID: 33510292 PMC: 7844051. DOI: 10.1038/s41598-021-81797-1.


References
1.
Pelliccia A, Maron B, Spataro A, Proschan M, Spirito P . The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991; 324(5):295-301. DOI: 10.1056/NEJM199101313240504. View

2.
Loffler M, Morote-Garcia J, Eltzschig S, Coe I, Eltzschig H . Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol. 2007; 27(5):1004-13. DOI: 10.1161/ATVBAHA.106.126714. View

3.
Radvan J, Choudhury L, Sheridan D, Camici P . Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy. Am J Cardiol. 1998; 80(12):1621-3. DOI: 10.1016/s0002-9149(97)00778-9. View

4.
Camici P, Crea F . Coronary microvascular dysfunction. N Engl J Med. 2007; 356(8):830-40. DOI: 10.1056/NEJMra061889. View

5.
Toraa M, Pouillard F, Merlet P, Friemel F . [Cardiac hypertrophy and coronary reserve in endurance athletes]. Can J Appl Physiol. 1999; 24(1):87-95. View